These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 30690717)
1. Efficient methods for signal detection from correlated adverse events in clinical trials. Diao G; Liu GF; Zeng D; Wang W; Tan X; Heyse JF; Ibrahim JG Biometrics; 2019 Sep; 75(3):1000-1008. PubMed ID: 30690717 [TBL] [Abstract][Full Text] [Related]
2. Bayesian approach for clinical trial safety data using an Ising prior. McEvoy BW; Nandy RR; Tiwari RC Biometrics; 2013 Sep; 69(3):661-72. PubMed ID: 23845253 [TBL] [Abstract][Full Text] [Related]
3. Controlling false discovery proportion in identification of drug-related adverse events from multiple system organ classes. Tan X; Liu GF; Zeng D; Wang W; Diao G; Heyse JF; Ibrahim JG Stat Med; 2019 Sep; 38(22):4378-4389. PubMed ID: 31313376 [TBL] [Abstract][Full Text] [Related]
4. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials. Odani M; Fukimbara S; Sato T Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578 [TBL] [Abstract][Full Text] [Related]
5. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Weng Y; Zhao W; Palesch Y Pharm Stat; 2012; 11(4):310-7. PubMed ID: 22589042 [TBL] [Abstract][Full Text] [Related]
6. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence. Xiao C; Li Y; Baytas IM; Zhou J; Wang F Sci Rep; 2018 Jan; 8(1):1806. PubMed ID: 29379048 [TBL] [Abstract][Full Text] [Related]
7. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584 [TBL] [Abstract][Full Text] [Related]
8. A nonparametric method to detect increased frequencies of adverse drug reactions over time. Heimann G; Belleli R; Kerman J; Fisch R; Kahn J; Behr S; Berlin C Stat Med; 2018 Apr; 37(9):1491-1514. PubMed ID: 29322542 [TBL] [Abstract][Full Text] [Related]
9. Detecting potential safety issues in large clinical or observational trials by Bayesian screening when event counts arise from poisson distributions. Gould AL J Biopharm Stat; 2013; 23(4):829-47. PubMed ID: 23786257 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721 [TBL] [Abstract][Full Text] [Related]
11. Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems. Gosho M; Maruo K; Tada K; Hirakawa A Eur J Clin Pharmacol; 2017 Jun; 73(6):779-786. PubMed ID: 28280890 [TBL] [Abstract][Full Text] [Related]
12. The methodology of safety data in clinical trials. Stephens MD Bratisl Lek Listy; 1991 Nov; 92(11):544-5. PubMed ID: 1806165 [TBL] [Abstract][Full Text] [Related]
14. Weighted multiple testing correction for correlated tests. Xie C Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000 [TBL] [Abstract][Full Text] [Related]
15. A hierarchical testing approach for detecting safety signals in clinical trials. Tan X; Chen BE; Sun J; Patel T; Ibrahim JG Stat Med; 2020 May; 39(10):1541-1557. PubMed ID: 32050050 [TBL] [Abstract][Full Text] [Related]